Entering text into the input field will update the search result below

Pieris Pharmaceuticals EPS beats by $0.02, beats on revenue

Aug. 04, 2021 7:19 AM ETPieris Pharmaceuticals, Inc. (PIRS) StockPIRSBy: Meghavi Singh, SA News Editor
  • Pieris Pharmaceuticals (NASDAQ:PIRS): Q2 GAAP EPS of -$0.25 beats by $0.02.
  • Revenue of $3.29M (-70.8% Y/Y) beats by $1.21M.
  • Cash and cash equivalents totaled $119.1M for the quarter ended June 30, 2021, compared to a cash and cash equivalents balance of $70.4M for the year ended December 31, 2020. 
  • Press Release

Recommended For You

More Trending News

About PIRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PIRS--
Pieris Pharmaceuticals, Inc.